DIN Lookup
Search Canadian Drug Identification Numbers and get detailed information
Showing results for DIN: 02142074
Drug Information
Class
Human (Humain)
Product Category
N/A
Last Updated
March 22, 2025
Active Ingredients
GEMFIBROZIL
Strength: 600 MG
Pharmaceutical Forms
TABLET
Routes of Administration
ORAL
Status Timeline
APPROVED
July 14, 2015
APPROVED
July 14, 2015
MARKETED
Current
July 14, 2015
MARKETED
June 10, 2014
APPROVED
June 9, 2014
APPROVED
May 16, 2014
MARKETED
December 31, 1995
Company Information
TEVA CANADA LIMITED
DIN_OWNER
30 NOVOPHARM COURT
TORONTO, ONTARIO
M1B 2K9
TORONTO, ONTARIO
M1B 2K9
Therapeutic Classes
ATC: C10AB04
Name: GEMFIBROZIL
AHFS:
Packaging Information
UPC:
Package Size:
Type:
Info: 100/500
Drug Type & Classification
Drug Type
Generic
Product Type
Prescription Pharmaceutical
Product Category
N/A
Drug Class
Human
Pediatric Flag
Not Pediatric
Active Ingredients
1 ingredient(s)
Notice of Compliance Information
NOC Number
5708
NOC Date
November 25, 1994
Submission Type
New Drug Submission (NDS)
Product Type
Prescription Pharmaceutical
Submission Class
Other
Manufacturer
NOVOPHARM LIMITED
Therapeutic Class
ANTIHYPERLIPIDEMIC AGENT
Notice of Compliance Ingredients
Ingredient: GEMFIBROZIL
Strength: 600.00000 MG
Basic Unit: TAB
Notice of Compliance Forms
Form: Tablet
Notice of Compliance Routes
Route: Oral
Related Products with Same Active Ingredients